Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment

被引：0
作者：
Arefeh Basiri
Fatemeh Mansouri
Arezo Azari
Parviz Ranjbarvan
Fateme Zarein
Arash Heidari
Ali Golchin
机构：
[1] Isfahan University of Medical Sciences,Department of Biomaterials and Tissue Engineering, School of Advanced Technologies in Medicine
[2] Universal Scientific Education and Research Network (USERN),Regenerative Medicine Group (REMED)
[3] Urmia University of Medical Sciences,Department of Genetics and Immunology, Faculty of Medicine
[4] Urmia University of Medical Sciences,Cellular and Molecular Research Center
[5] Shahid Beheshti University of Medical Sciences,Department of Tissue engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine
[6] Urmia University of Medical Sciences,Department of Clinical Biochemistry and Applied Cell Sciences, Faculty of Medicine
[7] Tarbiat Modares University,Department of Nanobiotechnology, faculty of biological sciences
[8] Tehran University of Medical Sciences,School of Medicine
来源：
Stem Cell Reviews and Reports | 2021年 / 17卷
关键词：
COVID-19; Personalized medicine; Cell-based therapy; Stem cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：193 / 213
页数：20
相关论文
共 667 条
[1]  
Golchin A(2020)Mesenchymal stem cell therapy for COVID-19: Present or future Stem Cell Reviews and Reports 16 427-433
[2]  
Seyedjafari E(2020)A novel coronavirus emerging in China — Key questions for impact assessment New England Journal of Medicine 382 692-694
[3]  
Ardeshirylajimi A(2020)A novel coronavirus from patients with pneumonia in China, 2019 New England Journal of Medicine 382 727-733
[4]  
Munster VJ(2020)The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- a n update on the status Military Medical Research. BioMed Central Ltd. 7 11-481
[5]  
Koopmans M(2020)Emerging trends in COVID-19 treatment: Learning from inflammatory conditions associated with cellular therapies Cytotherapy 22 474-e244
[6]  
van Doremalen N(2016)Global role and burden of influenza in pediatric respiratory hospitalizations, 1982–2012: A systematic analysis PLoS Medicine 13 e1001977-30
[7]  
van Riel D(2020)Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics The Lancet Infectious Diseases 20 e238-1534
[8]  
de Wit E(2020)COVID-19 and diabetes mellitus: From pathophysiology to clinical management Nature Reviews Endocrinology. 17 11-255
[9]  
Zhu N(2020)Genomewide association study of severe Covid-19 with respiratory failure New England Journal of Medicine 383 1522-574
[10]  
Zhang D(2020)Current status of cell-based therapies for respiratory virus infections: Applicability to COVID-19 The European respiratory journal. NLM (Medline). 55 2000858-273
12345678910